Recently, Chiatai Tianqing received the Certificate of Drug Registration approved and issued by the State Drug Administration (NMPA), in which the company's product Iopromide Injection in the field of medical imaging was approved to be listed and deemed to have passed the consistency evaluation as the second domestic one. Iopromide injection is a diagnostic drug, which can be used for intravascular and intracorporeal imaging, and is currently widely used in clinical applications and has great potential.

Iopromide is a tri-iodinated non-ionic water-soluble X-ray contrast agent with high iodine content and good contrast effect, which is used for computed tomography (CT) enhancement, arteriography and venography, arterial/venous digital subtraction angiography (DSA), cardiovascular angiography, venous urography, endoscopic retrograde cholangiopancreatography (ERCP), arthrocentesis, and other body cavity examinations. Iopromide has the advantages of stable nature, easy to use, lower toxic side effects than ionic iodine contrast agent, good systemic tolerance, etc., and has become a widely used iodine contrast agent in clinical practice.

With the in-depth promotion of universal health insurance and the wide application of medical imaging technology, China's contrast agent market demand is strong. The approval of Chiatai Tianqing Iodopromide Injection (Trademark name: Polyiodide) will provide more choices for the use of clinical iodine contrast agents.

In the field of medical imaging, Chiatai Tianqing has already approved the marketing of gadoxetic acid disodium (brand name: Xianai) and iodixanol (brand name: Sabian) in addition to iopromide injection (brand name: DuoIodine), and has several other projects under research and development, such as gadoteridol injection. With more products on the market, Chiatai Tianqing will gradually form a strong product matrix in the field of medical imaging to benefit more patients.

https://mp.weixin.qq.com/s?__biz=MzA5NDE4ODc2MA==&mid=2650365870&idx=1&sn=a5027a87a9b1c76dd456104f37c1159f&chksm=885f9a19bf28130ff3e35628b3d005a54799b0992efc886b579ae3898a12d3bc946e3f6780df&mpshare=1&scene=1&srcid=0326vkJtIFAGmDJNHLlsyFGk&sharer_shareinfo=bcc25bcad036a4e9241494b8e91cd2e8&sharer_shareinfo_first=bcc25bcad036a4e9241494b8e91cd2e8#rd